DAVID OURSO: Open Payments
NPI 1245771385 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,929 in 79 payments from 7 companies in 2025. Trend: 2023 $1,156 · 2024 $4,234 · 2025 $1,929
Food & beverage: $1,929
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 31 | $839 |
| Gilead Sciences, Inc. | 37 | $706 |
| Merck Sharp & Dohme LLC | 6 | $165 |
| EMD Serono, Inc. | 1 | $119 |
| Abbott Laboratories | 1 | $41 |
| Lilly USA, LLC | 2 | $40 |
| Theratechnologies Inc. | 1 | $18 |
Products named: CABENUVA, DOVATO, Biktarvy, PIFELTRO, Serostim, FREESTYLE LIBRE 3, ZEPBOUND, APRETUDE.
Industry payments across LA — which companies pay providers there.
